Donald G. Basel

Dr. Donald G. Basel

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
KDKerry Dwan
Kerry Dwan
CPCarrie A Phillipi
Carrie A Phillipi
RSRobert D Steiner
Robert D Steiner
DBDonald G. Basel
Donald G. Basel

23 July 2014
Verified
Reference Entry
Closed access
PDF file
KDKerry Dwan
Kerry Dwan
CPCarrie A Phillipi
Carrie A Phillipi
RSRobert D Steiner
Robert D Steiner
DBDonald G. Basel
Donald G. Basel

1 February 2017 in Pediatric Clinics of North America
Verified
Journal Article
Closed access
DBDonald G. Basel
Donald G. Basel
JMJulie McCarrier
Julie McCarrier

16 September 2022 in Genetics in Medicine
Verified
Journal Article
Open access
RSRavi Savarirayan
Ravi Savarirayan
MIMelita Irving
Melita Irving
PHpaul Harmatz
paul Harmatz
BDBorja Delgado
Borja Delgado
WWWilliam R. Wilcox
William R. Wilcox
JDJonathan Day
Jonathan Day
This study was undertaken to collect baseline growth parameters in children with achondroplasia who might enroll in interventional trials of vosoritide, and to establish a historical control. In this prospective, observational study, participants (≤17 years) underwent a detailed medical history and physical examination and were followed every 3 months until they finished participating in the study by enrolling in an interventional trial or withdrawing. A total of 363 children were enrolled (28 centers, 8 countries). Mean (SD) follow up was 20.4 (15.0) months. In participants <1 year, mean annualized growth velocity (AGV) was 11.6 cm/year for girls and 14.6 cm/year for boys. By age 1 year, mean AGV decreased to 7.4 cm/year in girls and 7.1 cm/year in boys. By age 10 years, mean AGV decreased to 3.6 cm/year for both sexes. Mean height z-score in participants <1 year was -2.5 for girls and -3.2 for boys and decreased up to the age 5 years (-5.3 for girls; -4.6 for boys). Girls and boys had a disproportionate upper-to-lower body segment ratio. Mean ratio was highest in participants aged <1 year (2.9 for girls; 2.8 for boys) and decreased gradually to approximately 2 in both sexes from 4 years of age onward. This study represents one of the largest datasets of prospectively collected medical and longitudinal growth data in children with achondroplasia. It serves as a robust historical control to measure therapeutic interventions against and to further delineate the natural history of this condition.

1 March 2020 in Clinics in Perinatology
Verified
Journal Article
Closed access
DBDonald G. Basel
Donald G. Basel

19 November 2013 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
BKBonita P. Klein-Tasman
Bonita P. Klein-Tasman
ACAlina M. Colon
Alina M. Colon
NBNatalie Brei
Natalie Brei
FFFaye van der Fluit
Faye van der Fluit
CCChristina L. Casnar
Christina L. Casnar
JWJasmine A. Walker
Jasmine A. Walker
Neurofibromatosis-1 is the most common single gene disorder affecting 1 in 3000. In children, it is associated not only with physical features but also with attention and learning problems. Research has identified a downward shift in intellectual functioning as well, but to date, there are no published studies about the everyday adaptive behavior of children with NF1. In this study, parental reports of adaptive behavior of 61 children with NF1 ages 3 through 8 were compared to an unaffected contrast group (n=55) that comprised siblings and community members. Significant group differences in adaptive skills were evident and were largely related to group differences in intellectual functioning. In a subsample of children with average-range intellectual functioning, group differences in parent-reported motor skills were apparent even after controlling statistically for group differences in intellectual functioning. The implications of the findings for the care of children with NF1 are discussed.